$1.960
+0.128 (+6.52%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PACB por análisis de gráficos similares
Alphio's PACB stock price prediction model matches the current Pacific Biosciences of California Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.96 (+0.05%). The 1-week path is $1.93 (-1.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Pacific Biosciences of California Inc?
Given the current price of $1.73 and the RSI at 24.595, which indicates the stock is oversold, it might seem like a potential buy. However, the significant risks include a recent 25.75% drop over the last five days and a lowered revenue guidance for 2026 to between $155 million and $165 million, down from $165 million to $175 million. These factors suggest that the stock may continue to face downward pressure, making it a risky investment at this time.
PACB cerró en $1.96 el Tuesday, tras subir +6.52%
Pacific Biosciences of California Inc (PACB) last closed at $1.96, gaining +6.52%. These facts feed the 1-day and 1-week PACB price prediction above.
Consenso de analistas
Pacific Biosciences of California Inc (PACB): 2 comprar, 4 mantener, 0 vender. Perspectiva: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Pacific Biosciences of California Inc (PACB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PACB, ordenadas por similitud.
Análisis de estacionalidad de PACB
Historically the probability of a positive October return for PACB is 36.67%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PACB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $0.86 | $0.93 | $1.07 | -52.41% |
| Nov 2026 | $0.83 | $0.98 | $0.99 | -50.08% |
| Dec 2026 | $0.96 | $0.99 | $1.08 | -49.46% |
En 2026, se proyecta que Pacific Biosciences of California Inc (PACB) oscile entre $0.83 y $1.08.
Previsión mensual de Pacific Biosciences of California Inc para 2026
En Oct de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.93, con un mínimo de $0.86 y un máximo de $1.07.
En Nov de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.98, con un mínimo de $0.83 y un máximo de $0.99.
En Dec de 2026, se proyecta que Pacific Biosciences of California Inc promedie $0.99, con un mínimo de $0.96 y un máximo de $1.08.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.